Inhibitory effects of the aqueous extract of Magnolia officinalis on the responses of human urinary bladder cancer 5637 cells in vitro and mouse urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in vivo

Phytotherapy Research

Volumn 23, Issue 1, 2009, Pages 20-27

  Lee, Se Jung ^a   Cho, Young Hwa ^b   Park, Keerang ^b   Kim, Eun Jung ^c   Kang, Bong Su ^c   Jung, Kyung Hwan ^a   Kim, Cheorl Ho ^d   Kim, Wun Jae ^c   Moon, Sung Kwon ^a  

^a Chungju National University   (South Korea)

^b Juseong College   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

^d Sungkyunkwan University   (South Korea)

Author keywords

5637 Cells; Apoptosis; Bax; Caspase 3; Cytochrome c; Magnolia officinalis; Matrix metalloproteinase; N butyl n (4 hydroxybutyl) nitrosamine; Urinary bladder tumor

Indexed keywords

CASPASE 3; CYTOCHROME C; DNA; EXTRACHROMOSOMAL DNA; GELATINASE A; GELATINASE B; MAGNOLIA OFFICINALIS EXTRACT; NITROSAMINE; PROTEIN BAX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CANCER; BLADDER TUMOR; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL VIABILITY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA HISTONE INTERACTION; DNA SYNTHESIS; FLUORESCENCE ACTIVATED CELL SORTING; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MAGNOLIACEAE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION; ZYMOGRAPHY;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BUTYLHYDROXYBUTYLNITROSAMINE; CARCINOMA, TRANSITIONAL CELL; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOCHROMES C; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MAGNOLIA; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; NUCLEIC ACID SYNTHESIS INHIBITORS; PLANT EXTRACTS; URINARY BLADDER NEOPLASMS;

MAGNOLIA OFFICINALIS; MUS;

EID: 58149485479     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2413     Document Type: Article

References (50)

1. Bai X, Cerimele F, Ushio-Fukai M et al. 2003. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 278: 35501-35507.
2. Battle TE, Arbiser J, Frank DA. 2005. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 106: 690-697.
3. Beckett RP, Davidson AH, Drummond AH, Huxley P, Whittaker M. 1996. Recent advances in matrix metalloproteinase inhibitor research. Drug Dev Today 1: 16-26.
4. Belotti D, Paganoni P, Manenti L et al. 2003. Matrix metallopro-teinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 63: 5224-5229.
5. Birkedal-Hansen H. 1995. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7: 728-735.
6. Burlacu A. 2003. Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 7: 249-257.
7. Cassileth BR, Deng G. 2004. Complementary and alternative therapies for cancer. Oncologist 9: 80-89.
8. Champelovier P, Simon A, Garrel C, Levacher G, Praloran V, Seigneurin D. 2003. Is interferon γ one key of metastatic potential increase in human bladder carcinoma? Clin Cancer Res 9: 4562-4569.
9. Chiarugi V, Ruggiero M. 1996. Role of three cancer 'master genes' p53, bcl2 and c-myc on the apoptotic process. Tumori 82: 205-209.
10. Cory S, Huang DC, Adams JM. 2003. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607.
11. Degli Esposti M, Dive C. 2003. Mitochondrial membrane permea-bilisation by Bax/Bak. Biochem Biophys Res Commun 304: 455-461.
12. Duffy MJ. 1992. The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 10: 145-155.
13. Fischer U, Janicke RU, Schulze-Osthoff K. 2003. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 10: 76-100.
14. Fong WF, Tse AK, Poon KH, Wang C. 2005. Magnolol and honokiol enhance HL-60 human leukemia cell differentiation induced by 1,25-dihydroxyvitamin D3 and retinoic acid. Int J Biochem Cell Biol 37: 427-441.
15. Goebell PJ, Villanueva CM, Rettenmeier AW, Rubben H, Kogevinas M. 2004. Environmental exposure, chlorinated drinking water, and bladder cancer. World J Urol 21: 424-432.
16. Gross A, Mcdonnell JM, Korsmeyer SJ. 1999. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911.
17. Grubbs CJ, Lubet RA, Koki AT et al. 2000. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res 60: 5599-5602.
18. Harada H, Grant S. 2003. Apoptosis regulators. Rev Clin Exp Hematol 7: 117-138.
19. Harnois C, Demers MJ, Bouchard V et al. 2004. Human intestinal epithelial crypt cell survival and death: complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways. J Cell Physiol 198: 209-222.
20. Hermanek P, Sobin LH. 1987. TNM Classification of Malignant Tumours, 4th edn. Springer-Verlag: Berlin, 197.
21. Hidalgo A, French-Constant C. 2003. The control of cell number during central nervous system development in flies and mice. Mech Dev 120: 1311-1325.
22. Hu W, Kavanagh JJ. 2003. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 4: 721-729.
23. Jemal A, Tiwari RC, Murray T et al. 2004. Cancer statistics. CA Cancer J Clin 54: 8-29.
24. Kucharczak J, Simmons M, Fan Y, Gelinas C. 2003. To be, or not to be: NF-kappaB is the answer - role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 22: 8961-8982.
25. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347.
26. Lee SJ, Kim HM, Cho YH et al. 2007. Aqueous extract of Magnolia officinalis mediates proliferative capacity, p21WAF1 expression and TNF-alpha-induced NF-kappaB activity in human urinary bladder cancer 5637 cells; involvement of p38 MAP kinase. Oncol Rep 18: 729-736.
27. Liotta LA. 1986. Tumor invasion and metastasis - role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res 46: 1-7.
28. Liotta LA, Rao CN, Barsky SH. 1983. Tumor invasion and extracellular matrix. Lab Invest 49: 636-649.
29. Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK. 2003. The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol 475: 19-27.
30. Lo YC, Teng CM, Chen CF, Chen CC, Hong CY. 1994. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochem Pharmacol 47: 549-553.
31. Maatta M, Soini Y, Liakka A, Autio-Harmainen H. 2000. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Clin Cancer Res 6: 2726-2734.
32. Moon SK, Cha BY, Kim CH. 2004a. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway. J Cell Physiol 198: 417-427.
33. Moon SK, Jung SY, Choi YH, Lee YC, Patterson C, Kim CH. 2004b. PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: involvement of p38 mitogen activated protein kinase. J Cell Physiol 198: 310-323.
34. Nakajima M, Lotan D, Baig MM et al. 1989. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res 49: 1698-1706.
35. Nicholson DW, Ali A, Thornberry NA et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43.
36. Park BC, Bosire KO, Lee ES, Lee YS, Kim JA. 2005. Asiatic acid induces apoptosis in SK-MEL-2 human melanoma cells. Cancer Lett 218: 81-90.
37. Park EJ, Zhao YZ, Kim YH, Lee BH, Sohn DH. 2005. Honokiol induces apoptosis via cytochrome c release and caspase activation in activated rat hepatic stellate cells in vitro. Planta Med 71: 82-84.
38. Primrose J, Bleiberg H, Daniel F et al. 1996. A dose-finding study of marimastat, an oral matrix metalloproteinase inhibitor, in patients with advanced colorectal cancer. Ann Oncol 7: 35.
39. Prout GR, Griffin PP, Shipley WU. 1979. Bladder carcinoma as systemic disease. Cancer 43: 2532-2539.
40. Reed JC. 2001. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med 7: 314-319.
41. Reich R, Thompson EW, Iwamoto Y et al. 1988. Effects of inhibitors of plasminogen activator, serine proteinases and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48: 3307-3312.
42. Stetler-Stevenson WG. 1990. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9: 289-303.
43. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. 1993. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573.
44. Teng CM, Chen CC, Ko FN et al. 1988. Two antiplatelet agents from Magnolia officinalis. Thromb Res 50: 757-765.
45. Tewari M, Quan LT, O'Rourke K et al. 1995. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801-809.
46. Tse AK, Wan CK, Shen XL, Yang M, Fong WF. 2005. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Biochem Pharmacol 70: 1443-1457.
47. Vaux DL, Korsmeyer SJ. 1999. Cell death in development. Cell 96: 245-254.
48. Wang T, Chen F, Chen Z et al. 2004. Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol 10: 2205-2208.
49. Yang J, Liu X, Bhalla K et al. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132.
50. Zeng ZS, Guillem JG. 1998. Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancer. Br J Cancer 78: 349-353.